Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
The U.S. Food and Drug Administration (FDA) recently granted marketing approval for Boston Scientific Corporation 's BSX Emblem MRI Subcutaneous Implantable Defibrillator (S-ICD) System, in line with ...
Silver Spring, MD - As expected, the S-ICD (Cameron Health/Boston Scientific) has become the first subcutaneous implantable cardioverter defibrillator available commercially in the US after the Food ...
Prominent cardiologist Robert Hauser has been known to ruffle feathers in the medical devices industry--and with his recent admonition of Boston Scientific's ($BSX ...
Implantation of an S-ICD in a Patient with a DDD Pacemaker and Congenitally Corrected Transposition of the Great Arteries In a new publication from Cardiovascular ...
In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...